{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:22:30Z","timestamp":1788416550477,"version":"build-2803163510"},"reference-count":35,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3892\/mmr.2015.3469","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T10:23:38Z","timestamp":1426069418000},"page":"1457-1464","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia"],"prefix":"10.3892","volume":"12","author":[{"given":"JIAN-YONG","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIU-HONG","family":"JIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAI-YAN","family":"XING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOU-JIE","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEN-WEN","family":"FAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NA","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHU-YANG","family":"XIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,3,11]]},"reference":[{"key":"key20180108022521_b1-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"key20180108022521_b2-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20180108022521_b3-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J Clin Invest"},{"key":"key20180108022521_b4-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jbior.2014.04.004","article-title":"Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells","volume":"56","author":"Martelli","year":"2014","journal-title":"Adv Biol Regul"},{"key":"key20180108022521_b5-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1515\/BC.2007.159","article-title":"FOXM1, a typical proliferation-associated transcription factor","volume":"388","author":"Wierstra","year":"2007","journal-title":"Biol Chem"},{"key":"key20180108022521_b6-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbagrm.2011.09.004","article-title":"FOXM1: From cancer initiation to progression and treatment","volume":"1819","author":"Koo","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"key20180108022521_b7-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1158\/1078-0432.CCR-11-1214","article-title":"Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients","volume":"17","author":"Priller","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180108022521_b8-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1479-5876-10-200","article-title":"Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma","volume":"10","author":"Xue","year":"2012","journal-title":"J Transl Med"},{"key":"key20180108022521_b9-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/MPA.0b013e31823bcef2","article-title":"Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma","volume":"41","author":"Xia","year":"2012","journal-title":"Pancreas"},{"key":"key20180108022521_b10-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"e59412","DOI":"10.1371\/journal.pone.0059412","article-title":"FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"key20180108022521_b11-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1479-5876-11-204","article-title":"Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel","volume":"11","author":"Li","year":"2013","journal-title":"J Transl Med"},{"key":"key20180108022521_b12-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2014.02.094","article-title":"Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia","volume":"446","author":"Liu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108022521_b13-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrc2223","article-title":"The emerging roles of forkhead box (Fox) proteins in cancer","volume":"7","author":"Myatt","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20180108022521_b14-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"e31761","DOI":"10.1371\/journal.pone.0031761","article-title":"Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage","volume":"7","author":"Halasi","year":"2012","journal-title":"PLoS One"},{"key":"key20180108022521_b15-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/carcin\/bgq185","article-title":"The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia","volume":"31","author":"Nakamura","year":"2010","journal-title":"Carcinogenesis"},{"key":"key20180108022521_b16-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-11-56","article-title":"The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol Cancer"},{"key":"key20180108022521_b17-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"e48160","DOI":"10.1371\/journal.pone.0048160","article-title":"Forkhead box M1 (FoxM1) gene is a new STAT3 transcriptional factor target and is essential for proliferation, survival and DNA repair of K562 cell line","volume":"7","author":"Mencalha","year":"2012","journal-title":"PloS one"},{"key":"key20180108022521_b18-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"e6593","DOI":"10.1371\/journal.pone.0006593","article-title":"FoxM1 is a general target for proteasome inhibitors","volume":"4","author":"Bhat","year":"2009","journal-title":"PLoS One"},{"key":"key20180108022521_b19-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nchem.1114","article-title":"The transcription factor FOXM1 is a cellular target of the natural product thiostrepton","volume":"3","author":"Hegde","year":"2011","journal-title":"Nat Chem"},{"key":"key20180108022521_b20-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nchem.1114","article-title":"The transcription factor FOXM1 is a cellular target of the natural product thiostrepton","volume":"3","author":"Hedge","year":"2011","journal-title":"Nat Chem"},{"key":"key20180108022521_b21-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4161\/cc.10.24.18544","article-title":"Thiostrepton, proteasome inhibitors and FOXM1","volume":"10","author":"Gartel","year":"2011","journal-title":"Cell Cycle"},{"key":"key20180108022521_b22-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4161\/cc.8.17.9414","article-title":"Wild-type p53 protects normal cells against apoptosis induced by thiostrepton","volume":"8","author":"Halasi","year":"2009","journal-title":"Cell Cycle"},{"key":"key20180108022521_b23-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/jc.2011-1506","article-title":"FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma","volume":"97","author":"Ahmed","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108022521_b24-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1158\/1535-7163.MCT-11-0536","article-title":"Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts","volume":"10","author":"Wang","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20180108022521_b25-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3892\/mmr.2013.1731","article-title":"Realgar induces apoptosis in the chronic lymphocytic leukemia cell line MEC1","volume":"8","author":"Liu","year":"2013","journal-title":"Mol Med Rep"},{"key":"key20180108022521_b26-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.lfs.2004.12.050","article-title":"Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562\/DOX) cells","volume":"77","author":"Ji","year":"2005","journal-title":"Life Sci"},{"key":"key20180108022521_b27-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2013","journal-title":"Blood"},{"key":"key20180108022521_b28-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"e5592","DOI":"10.1371\/journal.pone.0005592","article-title":"Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells","volume":"4","author":"Bhat","year":"2009","journal-title":"PLoS One"},{"key":"key20180108022521_b29-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3892\/or.2013.2654","article-title":"Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy","volume":"30","author":"Lin","year":"2013","journal-title":"Oncol Rep"},{"key":"key20180108022521_b30-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/1535-7163.MCT-12-0712","article-title":"FOX(M1) news - it is cancer","volume":"12","author":"Halasi","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"key20180108022521_b31-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1582-4934.2005.tb00361.x","article-title":"Survivin as a target for new anticancer interventions","volume":"9","author":"Zaffaroni","year":"2005","journal-title":"J Cell Mol Med"},{"key":"key20180108022521_b32-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1182\/blood-2003-12-4299","article-title":"Glutathione-S-transferase pi inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism","volume":"105","author":"Zhou","year":"2005","journal-title":"Blood"},{"key":"key20180108022521_b33-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3109\/10428194.2010.527402","article-title":"Polymorphisms of glutathione S-transferase mu 1, theta 1 and pi 1 genes and prognosis in Hodgkin lymphoma","volume":"51","author":"Lourenco","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"key20180108022521_b34-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0009-8981(02)00422-9","article-title":"Analysis of GSTP1\u20131 polymorphism using real-time polymerase chain reaction","volume":"329","author":"Ballerini","year":"2003","journal-title":"Clin Chim Acta"},{"key":"key20180108022521_b35-mmr-12-01-1457","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.tiv.2011.03.002","article-title":"Ligustrazine derivate DLJ14 reduces multidrug resistance of K562\/A02 cells by modulating GST\u03c0 activity","volume":"25","author":"Song","year":"2011","journal-title":"Toxicol In Vitro"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3469\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T04:28:22Z","timestamp":1515385702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,3,11]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3892\/mmr.2015.3469"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3469","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,11]]}}}